Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Blood Levels of Choline and Vitamin B12 in a Cohort of Canadian Pregnant Women and Newborn Infants

EF 2013-14

Résumé
Vitamin B12 and choline are water soluble nutrients that are required during pregnancy. The fetus cannot synthesize either nutrient, therefore, vitamin B12 and choline are transferred across the placenta from the mother to the fetus. Deficiencies in vitamin B12 and choline during pregnancy can cause serious adverse health outcomes, including abnormal fetal brain development, neural tube defects and intrauterine growth restrictions. Vitamin B12 and choline deficiency can be caused both by insufficient maternal dietary intake or genetic mutations leading to decreased blood levels. Currently, there is insufficient Canadian data concerning pregnant women’s dietary intakes and maternal and fetal blood levels of these nutrients. Furthermore, there is a lack of knowledge regarding the effects of genetic mutations of genes in the vitamin B12 and choline metabolic pathways on fetal nutrient blood levels. Optimal maternal intake and blood levels of vitamin B12 and choline during pregnancy must be established in order to reduce the occurrence of adverse health outcomes in the newborn infants. This study will assess the blood levels of vitamin B12, choline and their metabolites in a cohort of Canadian women during the early and late stages of pregnancy and in the newborn’s blood at delivery. Measurement of these nutrients and their metabolites will allow us to understand if maternal dietary intake influences maternal and fetal nutrient blood levels. We will also be able to determine if fluctuations in maternal nutrient blood levels during pregnancy are reflected in the fetal blood. Furthermore, this study will determine the effect of genetic mutations of genes in the vitamin B12 and choline metabolic pathways on fetal blood levels of vitamin B12, choline and their metabolites. Our group has recently completed a recruitment and sample collection involving 368 pregnant women at St. Michael’s Hospital in Toronto, ON. Blood was collected from the pregnant women at 12-16 weeks of gestation and at delivery. The newborn’s blood was collected at birth from the umbilical cord vein. Maternal dietary and supplemental intakes of vitamin B12 and choline during the early and late stages of pregnancy were recorded. Blood samples will be analyzed for levels of vitamin B12 and its metabolites (homocysteine and methylmalonic acid (MMA)) and choline and its metabolites (dimethylglycine, betaine and trimethylamine N-oxide). Determining the blood levels of these nutrients and their metabolites will allow us to understand the relationship between maternal dietary intakes and nutrient blood levels as well as the relationship between maternal blood levels and fetal blood levels. DNA extracted from cord blood lymphocytes will be analyzed for genetic mutations in order to establish a relationship between genetic variation and fetal nutrient and metabolite blood levels. Although vitamin B12 and choline are important nutritional factors for the development and growth of the fetus, optimal maternal dietary intake, as well as maternal and fetal blood levels, have not been well established in Canada. This study will provide a snapshot of the dietary intakes and blood levels of vitamin B12 and choline in a cohort of Canadian pregnant women and, as such, will help to shape Canadian public health recommendations in order to achieve optimal intakes and blood levels of these nutrients during pregnancy. This study will also provide novel information concerning the potential contribution of genetic mutations involved in vitamin B12 and choline metabolism on blood levels of these nutrients in the newborn infants.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
311879
Name
Visentin Carly E
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Blood Levels of Choline and Vitamin B12 in a Cohort of Canadian Pregnant Women and Newborn Infants
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Cancer; Choline; Dna Methylation; Epigenetics; Maternal Fetal Health; Nutrigenomics; Nutrition; One Carbon Metabolism; Single Nucleotide Polymorphisms; Vitamin B12
Abstract
Vitamin B12 and choline are water soluble nutrients that are required during pregnancy. The fetus cannot synthesize either nutrient, therefore, vitamin B12 and choline are transferred across the placenta from the mother to the fetus. Deficiencies in vitamin B12 and choline during pregnancy can cause serious adverse health outcomes, including abnormal fetal brain development, neural tube defects and intrauterine growth restrictions. Vitamin B12 and choline deficiency can be caused both by insufficient maternal dietary intake or genetic mutations leading to decreased blood levels. Currently, there is insufficient Canadian data concerning pregnant women’s dietary intakes and maternal and fetal blood levels of these nutrients. Furthermore, there is a lack of knowledge regarding the effects of genetic mutations of genes in the vitamin B12 and choline metabolic pathways on fetal nutrient blood levels. Optimal maternal intake and blood levels of vitamin B12 and choline during pregnancy must be established in order to reduce the occurrence of adverse health outcomes in the newborn infants. This study will assess the blood levels of vitamin B12, choline and their metabolites in a cohort of Canadian women during the early and late stages of pregnancy and in the newborn’s blood at delivery. Measurement of these nutrients and their metabolites will allow us to understand if maternal dietary intake influences maternal and fetal nutrient blood levels. We will also be able to determine if fluctuations in maternal nutrient blood levels during pregnancy are reflected in the fetal blood. Furthermore, this study will determine the effect of genetic mutations of genes in the vitamin B12 and choline metabolic pathways on fetal blood levels of vitamin B12, choline and their metabolites. Our group has recently completed a recruitment and sample collection involving 368 pregnant women at St. Michael’s Hospital in Toronto, ON. Blood was collected from the pregnant women at 12-16 weeks of gestation and at delivery. The newborn’s blood was collected at birth from the umbilical cord vein. Maternal dietary and supplemental intakes of vitamin B12 and choline during the early and late stages of pregnancy were recorded. Blood samples will be analyzed for levels of vitamin B12 and its metabolites (homocysteine and methylmalonic acid (MMA)) and choline and its metabolites (dimethylglycine, betaine and trimethylamine N-oxide). Determining the blood levels of these nutrients and their metabolites will allow us to understand the relationship between maternal dietary intakes and nutrient blood levels as well as the relationship between maternal blood levels and fetal blood levels. DNA extracted from cord blood lymphocytes will be analyzed for genetic mutations in order to establish a relationship between genetic variation and fetal nutrient and metabolite blood levels. Although vitamin B12 and choline are important nutritional factors for the development and growth of the fetus, optimal maternal dietary intake, as well as maternal and fetal blood levels, have not been well established in Canada. This study will provide a snapshot of the dietary intakes and blood levels of vitamin B12 and choline in a cohort of Canadian pregnant women and, as such, will help to shape Canadian public health recommendations in order to achieve optimal intakes and blood levels of these nutrients during pregnancy. This study will also provide novel information concerning the potential contribution of genetic mutations involved in vitamin B12 and choline metabolism on blood levels of these nutrients in the newborn infants.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Visentin, Carly E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~